ABT-202

ABT-202
Systematic (IUPAC) name
	(3S)-1-(pyridin-3-yl)pyrrolidin-3-amine
Clinical data
Pregnancy cat.	?
Legal status	?
Identifiers
ATC code	?
PubChem	CID 39220800
ChemSpider	16397614
Chemical data
Formula	C9H13N3
Mol. mass	163.219
SMILES	eMolecules & PubChem
	InChI InChI=1S/C9H13N3/c10-8-3-5-12(7-8)9-2-1-4-11-6-9/h1-2,4,6,8H,3,5,7,10H2 ; Key:LVGMMVAWLISWJD-UHFFFAOYSA-N ;
(what is this?) (verify);

From Wikipedia, the free encyclopedia

Jump to: navigation, search

ABT-202 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors and has been researched for use as an analgesic, although it has not passed clinical trials.^[1]^[2]

[edit] References

^ Jain, K. K. (2004). "Modulators of nicotinic acetylcholine receptors as analgesics". Current opinion in investigational drugs (London, England : 2000) 5 (1): 76–81. PMID 14983978. edit
^ Romanelli, M.; Gratteri, P.; Guandalini, L.; Martini, E.; Bonaccini, C.; Gualtieri, F. (2007). "Central nicotinic receptors: structure, function, ligands, and therapeutic potential". ChemMedChem 2 (6): 746–767. doi:10.1002/cmdc.200600207. PMID 17295372. edit

This analgesic-related article is a stub. You can help Wikipedia by expanding it.